Dicerna Pharma (DRNA) Tops Q4 EPS by 5c

Dicerna Pharma (NASDAQ: DRNA) reported Q4 EPS of ($0.68), $0.05 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c